Test Catalog

Test ID: B210R    
BCR/ABL1, p210, mRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Reflex

Useful For Suggests clinical disorders or settings where the test may be helpful

Diagnostic workup of patients with a high probability of BCR-ABL1-positive hematopoietic neoplasms, particularly chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia (B-lymphoblastic leukemia), to provide a pretreatment quantitative level of BCR-ABL1 mRNA transcript if the initial diagnostic RT-PCR screen is positive

 

When positive, the reflex test provides a quantitative value for the corresponding e13-a2 or e14-a2 (p210) BCR-ABL1 mRNA fusion variant

Method Name A short description of the method used to perform the test

Only orderable as a reflex. See BCRFX / BCR/ABL1 Qualitative Diagnostic Assay with Reflex to BCR/ABL1 p190 Quantitative Assay or BCR/ABL1 p210.

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

BCR/ABL1, p210, Quant, Reflex

Aliases Lists additional common names for a test, as an aid in searching

Philadelphia Chromosome Ph1 Bone Marrow/Blood
Philadelphia
BCR/ABL
Chronic Myelogenous Leukemia (CML)
CML (Chronic myeloid/Myelogenous Leukemia)